Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06109428 · ClinicalTrials.gov registry record · Phase 4
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE
A Phase 4 study, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT06109428: Completed Phase 4 study, sponsored by Heron Therapeutics.
NCT06109428 is a Phase 4 study that has completed, run by Heron Therapeutics. The registered enrollment target is 30 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06109428, a Phase 4 study, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing abdominoplasty (Cohort 2).
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Bupivacaine Hydrochloride
- DRUG HTX-011
- DEVICE Luer lock applicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-10-12 |
| Est. Completion | 2022-04-07 |
| Phase | Phase 4 |
What the finished NCT06109428 record still lists
NCT06109428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT06109428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06109428 about?
NCT06109428 is a clinical study titled "A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE". This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing abdominoplasty (Cohort 2).
What is the current status of trial NCT06109428?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2021-10-12. Estimated completion is 2022-04-07.
What interventions are being tested in trial NCT06109428?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Bupivacaine Hydrochloride (DRUG), HTX-011 (DRUG), Luer lock applicator (DEVICE).
Who is sponsoring clinical trial NCT06109428?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06109428's enrollment target sits among peer trials
30 1552nd of 2000 higher than 367 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI